Review
doi: 10.1016/j.msec.2017.04.068. Epub 2017 Apr 18.Non-viral strategies for ocular gene delivery
Affiliations
- PMID:28532005
- DOI: 10.1016/j.msec.2017.04.068
Item in Clipboard
Review
Non-viral strategies for ocular gene delivery
Ana V Oliveira et al. Mater Sci Eng C Mater Biol Appl..
Display options
Format
Display options
Format
Abstract
The success of gene therapy relies on efficient gene transfer and stable transgene expression. The in vivo efficiency is determined by the delivery vector, route of administration, therapeutic gene, and target cells. While some requirements are common to several strategies, others depend on the target disease and transgene product. Consequently, it is unlikely that a single system is suitable for all applications. This review examines current gene therapy strategies, focusing on non-viral approaches and the use of natural polymers with the eye, and particularly the retina, as their gene delivery target.
Keywords: Eye; Gene therapy; Non-viral vectors; Retina.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
- Self-focusing therapeutic gene delivery with intelligent gene vector swarms: intra-swarm signalling through receptor transgene expression in targeted cells.Tolmachov OE.Tolmachov OE.Artif Intell Med. 2015 Jan;63(1):1-6. doi: 10.1016/j.artmed.2014.11.001. Epub 2014 Dec 17.Artif Intell Med. 2015.PMID:25547266
- Treatment of ocular disorders by gene therapy.Solinís MÁ, del Pozo-Rodríguez A, Apaolaza PS, Rodríguez-Gascón A.Solinís MÁ, et al.Eur J Pharm Biopharm. 2015 Sep;95(Pt B):331-42. doi: 10.1016/j.ejpb.2014.12.022. Epub 2014 Dec 20.Eur J Pharm Biopharm. 2015.PMID:25536112Review.
- Current status of gene delivery and gene therapy in lacrimal gland using viral vectors.Selvam S, Thomas PB, Hamm-Alvarez SF, Schechter JE, Stevenson D, Mircheff AK, Trousdale MD.Selvam S, et al.Adv Drug Deliv Rev. 2006 Nov 15;58(11):1243-57. doi: 10.1016/j.addr.2006.07.021. Epub 2006 Sep 15.Adv Drug Deliv Rev. 2006.PMID:17056149Free PMC article.Review.
- Non-viral retinal gene therapy: a review.Charbel Issa P, MacLaren RE.Charbel Issa P, et al.Clin Exp Ophthalmol. 2012 Jan-Feb;40(1):39-47. doi: 10.1111/j.1442-9071.2011.02649.x. Epub 2011 Sep 19.Clin Exp Ophthalmol. 2012.PMID:21745262Review.
- Controlling the kinetics of interferon transgene expression for improved gene therapy.Watcharanurak K, Nishikawa M, Takahashi Y, Takakura Y.Watcharanurak K, et al.J Drug Target. 2012 Nov;20(9):764-9. doi: 10.3109/1061186X.2012.716848. Epub 2012 Sep 20.J Drug Target. 2012.PMID:22994266Review.
Cited by
- Mesoporous Silica Nanoparticles for Co-Delivery of Drugs and Nucleic Acids in Oncology: A Review.Paris JL, Vallet-Regí M.Paris JL, et al.Pharmaceutics. 2020 Jun 8;12(6):526. doi: 10.3390/pharmaceutics12060526.Pharmaceutics. 2020.PMID:32521800Free PMC article.Review.
- Effects of spinal non-viral interleukin-10 gene therapy formulated with d-mannose in neuropathic interleukin-10 deficient mice: Behavioral characterization, mRNA and protein analysis in pain relevant tissues.Vanderwall AG, Noor S, Sun MS, Sanchez JE, Yang XO, Jantzie LL, Mellios N, Milligan ED.Vanderwall AG, et al.Brain Behav Immun. 2018 Mar;69:91-112. doi: 10.1016/j.bbi.2017.11.004. Epub 2017 Nov 4.Brain Behav Immun. 2018.PMID:29113923Free PMC article.
- Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses.Ghoraba HH, Akhavanrezayat A, Karaca I, Yavari N, Lajevardi S, Hwang J, Regenold J, Matsumiya W, Pham B, Zaidi M, Mobasserian A, DongChau AT, Or C, Yasar C, Mishra K, Do D, Nguyen QD.Ghoraba HH, et al.Clin Ophthalmol. 2022 Jun 3;16:1753-1771. doi: 10.2147/OPTH.S364200. eCollection 2022.Clin Ophthalmol. 2022.PMID:35685379Free PMC article.Review.
- Recent Developments in Gene Therapy for Neovascular Age-Related Macular Degeneration: A Review.Finocchio L, Zeppieri M, Gabai A, Toneatto G, Spadea L, Salati C.Finocchio L, et al.Biomedicines. 2023 Dec 5;11(12):3221. doi: 10.3390/biomedicines11123221.Biomedicines. 2023.PMID:38137442Free PMC article.Review.
- Advancing precision medicines for ocular disorders: Diagnostic genomics to tailored therapies.Panikker P, Roy S, Ghosh A, Poornachandra B, Ghosh A.Panikker P, et al.Front Med (Lausanne). 2022 Jul 15;9:906482. doi: 10.3389/fmed.2022.906482. eCollection 2022.Front Med (Lausanne). 2022.PMID:35911417Free PMC article.Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources